[
  {
    "ts": null,
    "headline": "Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China",
    "summary": "Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China",
    "url": "https://finnhub.io/api/news?id=efa319d9fa0f321d56352fc5c54372c77440451a57901e61e620f3184ff00bed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732132329,
      "headline": "Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China",
      "id": 131539030,
      "image": "https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Update: Market Chatter: Johnson & Johnson, Merck Cut Jobs in China",
      "url": "https://finnhub.io/api/news?id=efa319d9fa0f321d56352fc5c54372c77440451a57901e61e620f3184ff00bed"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains",
    "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=83daa384d0fa4b50d05fac401095783019af1c433e1bc168b11db06b5b7c60a3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732120260,
      "headline": "Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains",
      "id": 131528750,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Wednesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=83daa384d0fa4b50d05fac401095783019af1c433e1bc168b11db06b5b7c60a3"
    }
  },
  {
    "ts": null,
    "headline": "Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy",
    "summary": "Top F500IL dividend stocks like AT&T, Altria, and Energy Transfer promise gains. Read why Energy Transfer stands as a safer choice.",
    "url": "https://finnhub.io/api/news?id=ccadc8f5e72aea70fa388baaa54e7a39c8e6cfc6c8a3c50207b5dc11274dde27",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732118725,
      "headline": "Of 63 Fortune 500 Industry Leaders, 57 Pay Dividends, 38 Are Cash Rich And 1 Is A Buy",
      "id": 131518616,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2155502722/image_2155502722.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Top F500IL dividend stocks like AT&T, Altria, and Energy Transfer promise gains. Read why Energy Transfer stands as a safer choice.",
      "url": "https://finnhub.io/api/news?id=ccadc8f5e72aea70fa388baaa54e7a39c8e6cfc6c8a3c50207b5dc11274dde27"
    }
  },
  {
    "ts": null,
    "headline": "Dr. Oz Goes From TV to the Most Important Job in Healthcare. Here’s What CMS Actually Does.",
    "summary": "Dr. Oz Goes From TV to the Most Important Job in Healthcare. Here’s What CMS Actually Does.",
    "url": "https://finnhub.io/api/news?id=2e47784e747fd3c00e4314ef7a55bf5d0852ef740278bb95556ba98a133f305e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732111740,
      "headline": "Dr. Oz Goes From TV to the Most Important Job in Healthcare. Here’s What CMS Actually Does.",
      "id": 131528388,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Dr. Oz Goes From TV to the Most Important Job in Healthcare. Here’s What CMS Actually Does.",
      "url": "https://finnhub.io/api/news?id=2e47784e747fd3c00e4314ef7a55bf5d0852ef740278bb95556ba98a133f305e"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting",
    "summary": "RARITAN - Johnson & Johnson announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society...",
    "url": "https://finnhub.io/api/news?id=38d7732c9d0eaa09f0c91a7994e02f15a77c74b1063e2a9bf84868d047193440",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732100912,
      "headline": "Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting",
      "id": 131504346,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "RARITAN - Johnson & Johnson announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society...",
      "url": "https://finnhub.io/api/news?id=38d7732c9d0eaa09f0c91a7994e02f15a77c74b1063e2a9bf84868d047193440"
    }
  },
  {
    "ts": null,
    "headline": "XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)",
    "summary": "We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.",
    "url": "https://finnhub.io/api/news?id=fda1041225add2352abc51ab2126c9563bd38831235bdf55044cf40be42ddef3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732093680,
      "headline": "XLV: Healthcare Stocks In Critical Condition (Rating Downgrade)",
      "id": 131502070,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1496411389/image_1496411389.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "We advise selling healthcare stocks due to political uncertainty and unfavorable market conditions, prioritizing low-risk investments. See more on XLV ETF here.",
      "url": "https://finnhub.io/api/news?id=fda1041225add2352abc51ab2126c9563bd38831235bdf55044cf40be42ddef3"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys",
    "summary": "Investment activity in October focused on Business Development Companies. Check out my portfolio, my main picks, and my target for 2024.",
    "url": "https://finnhub.io/api/news?id=ee2c0c1844905ec03a4c7fe82d622e1f1a4eac7b2c437722a3c253267dbcb25d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732090200,
      "headline": "My Dividend Stock Portfolio: New October Dividend Record - 100 Holdings With 15 Buys",
      "id": 131501184,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Investment activity in October focused on Business Development Companies. Check out my portfolio, my main picks, and my target for 2024.",
      "url": "https://finnhub.io/api/news?id=ee2c0c1844905ec03a4c7fe82d622e1f1a4eac7b2c437722a3c253267dbcb25d"
    }
  },
  {
    "ts": null,
    "headline": "BlackRock Advantage Global Fund Q3 2024 Commentary",
    "summary": "The fund posted returns of 5.38% (Institutional shares) and 5.32% (Investor A shares, without sales charge) for the third quarter of 2024.",
    "url": "https://finnhub.io/api/news?id=0b261e44b132339ddcb68f9ea92ad819709097f46528a8530d8fda0da6965844",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732086000,
      "headline": "BlackRock Advantage Global Fund Q3 2024 Commentary",
      "id": 131499797,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2149260996/image_2149260996.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "The fund posted returns of 5.38% (Institutional shares) and 5.32% (Investor A shares, without sales charge) for the third quarter of 2024.",
      "url": "https://finnhub.io/api/news?id=0b261e44b132339ddcb68f9ea92ad819709097f46528a8530d8fda0da6965844"
    }
  }
]